<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>Tan Lines</title><description>The full Melanotan II story, told straight: the research that created it, the gray market that hijacked it, the approved drugs it spawned, and the photoprotective medicine that could still come.</description><link>https://melanotanii.com/</link><language>en-us</language><item><title>The nasal-spray myth: why needle-free isn&apos;t safer</title><link>https://melanotanii.com/articles/the-nasal-spray-myth/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-nasal-spray-myth/</guid><description>A Melanotan II nasal spray changes the packaging, not the molecule. Why &apos;needle-free&apos; removes the one thing an injection gives — a known dose.</description><pubDate>Tue, 29 Sep 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>A ban with no borders: how each country tried to stop Melanotan II</title><link>https://melanotanii.com/articles/the-enforcement-map/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-enforcement-map/</guid><description>Melanotan II is unapproved almost everywhere. A country-by-country map of how the UK, Australia, Ireland and US fought the gray market — and why it held.</description><pubDate>Thu, 24 Sep 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>The class is moving: the melanocortin sun drugs actually in trials now</title><link>https://melanotanii.com/articles/the-pipeline-right-now/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-pipeline-right-now/</guid><description>A 2026 snapshot of the melanocortin drugs in real development: an oral MC1R agonist near FDA decision, and an approved one expanding into vitiligo and repair.</description><pubDate>Thu, 24 Sep 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>The attribution gap: why &apos;no deaths reported&apos; isn&apos;t a safety record</title><link>https://melanotanii.com/articles/safety-by-numbers/</link><guid isPermaLink="true">https://melanotanii.com/articles/safety-by-numbers/</guid><description>Millions of users, no deaths — the gray market&apos;s core safety claim fails at both numbers. A BMJ editorial, a Bolton inquest, and 89 counted reports explain why.</description><pubDate>Mon, 14 Sep 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>A drug before its receptor: how the Arizona team built Melanotan in the dark</title><link>https://melanotanii.com/articles/before-the-receptor/</link><guid isPermaLink="true">https://melanotanii.com/articles/before-the-receptor/</guid><description>Melanotan II was designed before its receptors were discovered — using frog-skin assays and two amino-acid swaps that made a superpotent α-MSH analog.</description><pubDate>Sun, 13 Sep 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>One letter, two different molecules</title><link>https://melanotanii.com/articles/not-melatonin/</link><guid isPermaLink="true">https://melanotanii.com/articles/not-melatonin/</guid><description>Melanotan and melatonin are one letter apart and nothing else alike: a sleep supplement versus an unapproved tanning peptide. Why the mix-up matters.</description><pubDate>Sun, 30 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>The natural fallacy: what your body actually does with α-MSH</title><link>https://melanotanii.com/articles/the-natural-fallacy/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-natural-fallacy/</guid><description>Melanotan II is sold as a &apos;natural&apos; hormone your body already makes. It mimics α-MSH — but your body keeps that signal local and brief for a reason.</description><pubDate>Sun, 30 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>The pill that wasn&apos;t: why there is no oral Melanotan II</title><link>https://melanotanii.com/articles/the-pill-that-wasnt/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-pill-that-wasnt/</guid><description>Melanotan II sold as a capsule, gummy, or drink can&apos;t work: a cyclic peptide doesn&apos;t survive digestion. What &apos;oral melanotan&apos; actually is.</description><pubDate>Sun, 30 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>The prevention claim, misread: what the trials showed, what the captions say</title><link>https://melanotanii.com/articles/the-prevention-claim-misread/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-prevention-claim-misread/</guid><description>&apos;Melanotan prevents skin cancer&apos; is a caption-level fact. The trials never tested that. What the evidence shows, what the claim sells, and the gap between.</description><pubDate>Sun, 30 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>The protocol illusion: why dosing math can&apos;t fix a vial nobody tested</title><link>https://melanotanii.com/articles/the-protocol-illusion/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-protocol-illusion/</guid><description>Online Melanotan II guides carry titration schedules, reconstitution math, maintenance plans. The numbers are theatre — arithmetic on an unknown vial.</description><pubDate>Sun, 30 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>The third rebrand: a gray-market tan on the wellness menu</title><link>https://melanotanii.com/articles/the-wellness-menu/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-wellness-menu/</guid><description>Wellness clinics now sell Melanotan II as a longevity peptide. Real melanocortin drugs exist — approved, selective, monitored. This isn&apos;t one of them.</description><pubDate>Sun, 30 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>A drug with no address: the pharmacokinetics of doing everything at once</title><link>https://melanotanii.com/articles/a-drug-with-no-address/</link><guid isPermaLink="true">https://melanotanii.com/articles/a-drug-with-no-address/</guid><description>Why one dose of Melanotan II tans, sickens, and arouses at once: its pharmacokinetics give it no address. It floods the body and outlasts the signal it mimics.</description><pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>How it&apos;s sold now: the market that can&apos;t say its own name</title><link>https://melanotanii.com/articles/how-its-sold-now/</link><guid isPermaLink="true">https://melanotanii.com/articles/how-its-sold-now/</guid><description>Research-chemical storefronts, banned hashtags, influencer commissions, salon shelves, disguised payments — the supply machine that sells Melanotan II now.</description><pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>MC1R variants: why the tanning response isn&apos;t universal</title><link>https://melanotanii.com/articles/mc1r-variants-not-universal/</link><guid isPermaLink="true">https://melanotanii.com/articles/mc1r-variants-not-universal/</guid><description>Red hair is the loud end. Most MC1R variants are quieter: r alleles, heterozygotes, East Asian R163Q. A future agonist would not reach everyone who burns.</description><pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>What the warnings actually did: a decade of Melanotan II enforcement</title><link>https://melanotanii.com/articles/what-the-warnings-actually-did/</link><guid isPermaLink="true">https://melanotanii.com/articles/what-the-warnings-actually-did/</guid><description>Regulators seized sites, parcels, and sellers. Australia made possession a crime. The market moved to nasal sprays. Why enforcement keeps losing.</description><pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>Two names on the patent: who owned Melanotan, and how it got loose</title><link>https://melanotanii.com/articles/who-owned-melanotan/</link><guid isPermaLink="true">https://melanotanii.com/articles/who-owned-melanotan/</guid><description>How a University of Arizona peptide became two FDA drugs and a gray-market staple: the patent trail from Hruby and Hadley to Clinuvel and Palatin.</description><pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>Who would pay for the trial: the sponsor problem</title><link>https://melanotanii.com/articles/who-would-pay-for-the-trial/</link><guid isPermaLink="true">https://melanotanii.com/articles/who-would-pay-for-the-trial/</guid><description>Clinuvel profits from a rare-disease implant. Novo funds prevention trials insurers pay for. A general-public sun drug needs both, and has neither.</description><pubDate>Wed, 26 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>The Barbie drug: how an unapproved peptide built a global gray market</title><link>https://melanotanii.com/articles/barbie-drug-gray-market/</link><guid isPermaLink="true">https://melanotanii.com/articles/barbie-drug-gray-market/</guid><description>Never approved anywhere, Melanotan II sold anyway — through forums, gyms, and &apos;research chemical&apos; sites. How the gray market formed, and what it costs.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>How a suntan became desirable</title><link>https://melanotanii.com/articles/how-a-suntan-became-desirable/</link><guid isPermaLink="true">https://melanotanii.com/articles/how-a-suntan-became-desirable/</guid><description>For most of history a tan meant labor; then, in one decade, it flipped. How Chanel, the Riviera, and the sunbed made tanned skin aspirational.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>How a tan actually protects skin — and why that was the whole idea</title><link>https://melanotanii.com/articles/how-a-tan-protects-skin/</link><guid isPermaLink="true">https://melanotanii.com/articles/how-a-tan-protects-skin/</guid><description>A tan is the body&apos;s sunscreen: eumelanin absorbing UV before it reaches DNA. How melanin protects skin — and why that was Melanotan&apos;s target.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>How the science escaped the lab: the patents that made a gray market inevitable</title><link>https://melanotanii.com/articles/how-the-science-escaped-the-lab/</link><guid isPermaLink="true">https://melanotanii.com/articles/how-the-science-escaped-the-lab/</guid><description>Melanotan II&apos;s recipe was published in journals and patents, then orphaned by its developers. Public structure plus real demand made the gray market inevitable.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>Melanotan I and Melanotan II: one number, two completely different fates</title><link>https://melanotanii.com/articles/melanotan-1-vs-melanotan-2/</link><guid isPermaLink="true">https://melanotanii.com/articles/melanotan-1-vs-melanotan-2/</guid><description>Melanotan I vs Melanotan II: near-identical peptides from the same Arizona lab. One became an approved medicine; the other, the gray market&apos;s favorite. Why.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>The middle-ground agonist already exists. You just can&apos;t have it.</title><link>https://melanotanii.com/articles/middle-ground-agonist-already-exists/</link><guid isPermaLink="true">https://melanotanii.com/articles/middle-ground-agonist-already-exists/</guid><description>Afamelanotide (Scenesse) is an approved melanocortin drug that protects skin from light — locked in a rare-disease label. Why, and what a breakout would take.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>One hormone, five receptors: why Melanotan II did so much more than tan</title><link>https://melanotanii.com/articles/one-hormone-five-receptors/</link><guid isPermaLink="true">https://melanotanii.com/articles/one-hormone-five-receptors/</guid><description>Why Melanotan II tans, suppresses appetite, and affects libido at once: one non-selective agonist hitting all five melanocortin receptors.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>Tanorexia: the opioid your skin makes in the sun</title><link>https://melanotanii.com/articles/tanorexia-the-opioid-your-skin-makes/</link><guid isPermaLink="true">https://melanotanii.com/articles/tanorexia-the-opioid-your-skin-makes/</guid><description>UV light makes skin manufacture its own opioid — the hidden reward inside every tan. The science of tanning dependence, and what it says about Melanotan.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>One injection, eight hours, and a second drug hiding inside Melanotan II</title><link>https://melanotanii.com/articles/the-accident-inside-melanotan/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-accident-inside-melanotan/</guid><description>A University of Arizona self-experiment with Melanotan II produced an eight-hour erection — and pointed the way to an FDA-approved libido drug.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>The beachhead: the narrow uses that could open the door for everyone</title><link>https://melanotanii.com/articles/the-beachhead-indications/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-beachhead-indications/</guid><description>How a photoprotective melanocortin drug could reach everyone: beachhead indications, from approved EPP to a vitiligo trial now in Phase III.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>The influencer era: how the Barbie drug got re-sold</title><link>https://melanotanii.com/articles/the-influencer-era/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-influencer-era/</guid><description>How Melanotan II went viral: nasal sprays, flavored drops, and the TikTok &apos;vacation peptide&apos; re-packaged an unregulated injectable for the open market.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>The mole problem: what dermatologists actually fear about Melanotan II</title><link>https://melanotanii.com/articles/the-mole-problem/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-mole-problem/</guid><description>Melanotan II darkens and multiplies moles — and the deeper danger is diagnostic: the case reports, the melanoma question, and the signals you lose.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>The prevention-trial problem: why &apos;stops skin cancer&apos; is so hard to prove</title><link>https://melanotanii.com/articles/the-prevention-trial-problem/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-prevention-trial-problem/</guid><description>Proving a drug prevents skin cancer needs one of the longest, largest trials in medicine. Why the evidence bar — not the chemistry — is the real wall.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>The side-effect ledger: what Melanotan II is actually documented to do</title><link>https://melanotanii.com/articles/the-side-effect-ledger/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-side-effect-ledger/</guid><description>Melanotan II side effects, sorted by evidence: the documented acute and pigment effects, and the rare serious events that reach the medical literature.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>The tan without the sun: what a peptide short-circuits that UV does the hard way</title><link>https://melanotanii.com/articles/the-tan-without-the-sun/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-tan-without-the-sun/</guid><description>A suntan is a wound response: pigment made only after UV has damaged skin DNA. Melanotan&apos;s idea was the protection without the damage.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item><item><title>The three doors: the U.S. regulatory map for a melanocortin sun drug</title><link>https://melanotanii.com/articles/the-three-doors/</link><guid isPermaLink="true">https://melanotanii.com/articles/the-three-doors/</guid><description>Is Melanotan II legal in the U.S.? It&apos;s unapproved — but the technology isn&apos;t. The three doors: FDA approval, compounding, and the gray market.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>What a safe tanning drug would actually have to be</title><link>https://melanotanii.com/articles/what-a-safe-tanning-drug-requires/</link><guid isPermaLink="true">https://melanotanii.com/articles/what-a-safe-tanning-drug-requires/</guid><description>The four requirements a general-public photoprotective drug must clear — and how far today&apos;s science already is toward each. Analysis, labeled as such.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>next-agonist</category></item><item><title>You can&apos;t know what&apos;s in the vial</title><link>https://melanotanii.com/articles/whats-in-the-vial/</link><guid isPermaLink="true">https://melanotanii.com/articles/whats-in-the-vial/</guid><description>Gray-market Melanotan II comes from unknown labs: purity, sterility, and dose are all assumptions — and assumptions have sent people to the ER.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>cautionary-tale</category></item><item><title>The sunscreen you&apos;d never have to reapply: where Melanotan came from</title><link>https://melanotanii.com/articles/where-melanotan-came-from/</link><guid isPermaLink="true">https://melanotanii.com/articles/where-melanotan-came-from/</guid><description>Melanotan II began as 1980s melanoma-prevention research at the University of Arizona — an injectable sunscreen. The origin story of the tanning peptide.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>history</category></item><item><title>Why a cosmetic went underground</title><link>https://melanotanii.com/articles/why-a-cosmetic-went-underground/</link><guid isPermaLink="true">https://melanotanii.com/articles/why-a-cosmetic-went-underground/</guid><description>Why Melanotan II became the most self-injected unapproved drug: it served a want, not a need — and wants don&apos;t wait for clinical trials.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>culture</category></item><item><title>Why redheads burn: the MC1R gene and the pigment switch</title><link>https://melanotanii.com/articles/why-redheads-burn-mc1r/</link><guid isPermaLink="true">https://melanotanii.com/articles/why-redheads-burn-mc1r/</guid><description>Red hair, freckles, and burning instead of tanning trace to one receptor: MC1R. The keyhole every Melanotan was cut to fit — and a melanoma risk gene.</description><pubDate>Tue, 18 Aug 2026 00:00:00 GMT</pubDate><category>science</category></item></channel></rss>